the risk of developing a syndrome resembling lupus erythematosus when taking procainamide has been well recognized for over 15 years , although the development of myopathy has been reported on one occasion only , in this instance without histopathological evidence of muscle inflammation .
C0026848
myopathy
C0027121
muscle inflammation